Related references
Note: Only part of the references are listed.Prevalence of Valvular Heart Disease in a Cohort of Patients Taking Cabergoline for Management of Hyperprolactinemia
Jessica Devin et al.
Endocrine Practice (2013)
Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study
Lisa B. Nachtigall et al.
CLINICAL ENDOCRINOLOGY (2010)
Assessment of cardiac valve dysfunction in patients receiving cabergoline treatment for hyperprolactinaemia
Tricia Tan et al.
CLINICAL ENDOCRINOLOGY (2010)
Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline
M. Lafeber et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Prolactinomas
Anne Klibanski
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Valvular heart disease and the use of cabergoline for the treatment of prolactinoma
Neil Herring et al.
CLINICAL ENDOCRINOLOGY (2009)
Drug-induced fibrotic valvular heart disease
Sanjeev Bhattacharyya et al.
LANCET (2009)
Bromocriptine Use and the Risk of Valvular Heart Disease
Louis C. S. Tan et al.
MOVEMENT DISORDERS (2009)
Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas
Sophie Vallette et al.
PITUITARY (2009)
Cabergoline and the risk of valvular lesions in endocrine disease
Patrizio Lancellotti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Low dose cabergoline for hyperprolactinaemia is not associated with clinically significant valvular heart disease
Ammar Wakil et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia
F. Bogazzi et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Aortic valve calcification and mild tricuspid regurgitation but no clinical heart disease after 8 years of dopamine agonist therapy for prolactinoma
Marleen Kars et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Increased prevalence of tricuspid regurgitation in patients with Prolactinomas chronically treated with cabergoline
Annamaria Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine Agonists
Gregor Simonis et al.
MOVEMENT DISORDERS (2007)
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research
James D. Lewis et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Dopamine agonists and the risk of cardiac-valve regurgitation
Rene Schade et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Valvular heart disease and the use of dopamine agonists for Parkinson's disease
Renzo Zanettini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Dopamine agonists and cardiac valvulopathy in Parkinson disease - A case-control study
Mitsutoshi Yamamoto et al.
NEUROLOGY (2006)
Valvular heart disease in Parkinson's disease vs. controls:: An echocardiographic study
Cecilia Peralta et al.
MOVEMENT DISORDERS (2006)
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists
Trond Kvernmo et al.
CLINICAL THERAPEUTICS (2006)
Cabergoline-related severe restrictive mitral regurgitation
A Pinero et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Evidence-based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004
CG Goetz et al.
MOVEMENT DISORDERS (2005)
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease
G Van Camp et al.
LANCET (2004)
An incidence density sampling program for nested case-control analyses
DB Richardson
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2004)
Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists
J Horvath et al.
MOVEMENT DISORDERS (2004)
Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide
G Van Camp et al.
NEUROLOGY (2003)
Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases
C Cricelli et al.
JOURNAL OF PUBLIC HEALTH MEDICINE (2003)
VaIvular heart disease in patients taking pergolide
AM Pritchett et al.
MAYO CLINIC PROCEEDINGS (2002)
Share Paper
